Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,112 public trials 3,999 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Mosaic Trial for Stem Cell Transplant Recipients

NCT06960993

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Bone Marrow Transplant, +22 more
Locations
  • Georgetown University School of Medicine Washington D.C., District of Columbia, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Hackensack Meridian Health Nutley, New Jersey, United States
View Trial Details
Recruiting

A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (AMMADINA)

NCT07742215

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • SI "Republican Scientific and Practical Center for Radiation Medicine and Human Ecology" Homyel, Belarus
  • SBHI "Chelyabinsk regional clinical hospital" Chelyabinsk, Russia
  • SBHI "Regional oncological dispensary" Irkutsk, Russia
  • SAHI "Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigal" Kazan', Russia
View all 16 locations
View Trial Details
Recruiting

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

NCT07069699

Conditions
Burkitt Lymphoma, DNA Virus Infections, Double-Expressor Lymphoma, +16 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of Kansas Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
View Trial Details
Recruiting

Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia

NCT06965114

Conditions
Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • NCI - Center for Cancer Research Bethesda, Maryland, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • University of Virginia Cancer Center Charlottesville, Virginia, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

Blinatumomab Consolidation in Real World

NCT07117136

Conditions
B-Cell Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Mayo Clinic Cancer Center Jacksonville, Florida, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

NCT06708897

Conditions
Blood Protein Disorders, CLL (Chronic Lymphocytic Leukemia), CLL / SLL, +32 more
Locations
  • Norton Cancer Institute, St. Matthews Campus Louisville, Kentucky, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details

Related conditions